| Symbol | ATAI |
|---|---|
| Name | ATAIBECKLEY INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | C/O ATAI LIFE SCIENCES US, INC., NEW YORK, NY 10119 |
| Telephone | 1 929 207 2670 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
Craig Kevin James 🟡 adjusted position in 42.6K shares (2 derivative) of AtaiBeckley Inc. (ATAI) at $5.00 Transaction Date: Apr 20, 2026 | Filing ID: 016169
Read moreNew Form DEFA14A - AtaiBeckley Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001140361-26-016163 <b>Size:</b> 8 MB
Read moreNew Form DEF 14A - AtaiBeckley Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001140361-26-016161 <b>Size:</b> 4 MB
Read more📋 KEVIN JAMES CRAIG (Officer) plans to sell 43K shares of ATAI BECKLEY INC (at $4.03 each, total $172K) Filed: Apr 20, 2026 | ID: 003650
Read moreAngermayer Christian 🟡 adjusted position in 0 shares (3 derivative) of AtaiBeckley Inc. (ATAI) at $1.88 ($1.8M) Transaction Date: Apr 08, 2026 | Filing ID: 014300
Read moreAtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
Read moreAtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
Read moreBPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
Read moreBPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
Read moreAtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update
Read more